Archimedes Tech SPAC Partners III (ARCI)
Market Price (6/1/2026): $9.98 | Market Cap: $-Sector: Financials | Industry: Multi-Sector Holdings
Archimedes Tech SPAC Partners III (ARCI)
Market Price (6/1/2026): $9.98Market Cap: $-Sector: FinancialsIndustry: Multi-Sector Holdings
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Low stock price volatilityVol 12M is 2.6% | Trading close to highsDist 52W High is 0.0%, Dist 3Y High is 0.0% Weak multi-year price returns2Y Excs Rtn is -42%, 3Y Excs Rtn is -81% | Key risksARCI key risks include [1] the failure to complete a business combination within its mandated timeframe, Show more. |
| Low stock price volatilityVol 12M is 2.6% |
| Trading close to highsDist 52W High is 0.0%, Dist 3Y High is 0.0% |
| Weak multi-year price returns2Y Excs Rtn is -42%, 3Y Excs Rtn is -81% |
| Key risksARCI key risks include [1] the failure to complete a business combination within its mandated timeframe, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Updated on 5/1/2026
Archimedes Tech SPAC Partners III (ARCI) stock has remained largely at the same level since it went public on 3/16/2026 because of the following key factors:
1. Inherent Nature as a Special Purpose Acquisition Company (SPAC) Awaiting Business Combination.
Archimedes Tech SPAC Partners III (ARCI) is a blank-check company, meaning its primary purpose is to raise capital through an Initial Public Offering (IPO) to acquire an existing private company. SPACs typically price their units at $10.00 per share during their IPO, which was the case for ARCI units. Before a definitive merger target is identified and announced, the stock often trades around this initial price point, as its value is primarily tied to the cash held in trust rather than an operating business. ARCI's stock has remained largely within a narrow range, for instance, showing a 52-week trading range between a low of $9.83 and a high of $10.06.
2. Absence of a Definitive Merger Announcement.
A core reason for ARCI's stable stock price is the absence of a publicly announced definitive agreement for a business combination (de-SPAC) since it began trading as ARCI on March 16, 2026. Without a specific target acquisition, there is no new company-specific information or operational performance to significantly influence investor sentiment and drive the stock price beyond its foundational value as a cash shell. SPACs have a set timeframe, usually 18 to 24 months from their IPO, to complete a merger.
Show more
Archimedes Tech SPAC Partners III (ARCI) stock has remained largely at the same level since it went public on 3/16/2026 because of the following key factors:
1. Inherent Nature as a Special Purpose Acquisition Company (SPAC) Awaiting Business Combination.
Archimedes Tech SPAC Partners III (ARCI) is a blank-check company, meaning its primary purpose is to raise capital through an Initial Public Offering (IPO) to acquire an existing private company. SPACs typically price their units at $10.00 per share during their IPO, which was the case for ARCI units. Before a definitive merger target is identified and announced, the stock often trades around this initial price point, as its value is primarily tied to the cash held in trust rather than an operating business. ARCI's stock has remained largely within a narrow range, for instance, showing a 52-week trading range between a low of $9.83 and a high of $10.06.
2. Absence of a Definitive Merger Announcement.
A core reason for ARCI's stable stock price is the absence of a publicly announced definitive agreement for a business combination (de-SPAC) since it began trading as ARCI on March 16, 2026. Without a specific target acquisition, there is no new company-specific information or operational performance to significantly influence investor sentiment and drive the stock price beyond its foundational value as a cash shell. SPACs have a set timeframe, usually 18 to 24 months from their IPO, to complete a merger.
Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →
Stock Movement Drivers
Fundamental Drivers
nullnull
Market Drivers
2/28/2026 to 5/31/2026| Return | Correlation | |
|---|---|---|
| ARCI | ||
| Market (SPY) | 10.6% | 31.7% |
| Sector (XLF) | 0.8% | 13.6% |
Fundamental Drivers
nullnull
Market Drivers
11/30/2025 to 5/31/2026| Return | Correlation | |
|---|---|---|
| ARCI | ||
| Market (SPY) | 11.3% | 31.7% |
| Sector (XLF) | -2.4% | 13.6% |
Fundamental Drivers
nullnull
Market Drivers
5/31/2025 to 5/31/2026| Return | Correlation | |
|---|---|---|
| ARCI | ||
| Market (SPY) | 29.8% | 31.7% |
| Sector (XLF) | 2.8% | 13.6% |
Fundamental Drivers
nullnull
Market Drivers
5/31/2023 to 5/31/2026| Return | Correlation | |
|---|---|---|
| ARCI | ||
| Market (SPY) | 88.1% | 31.7% |
| Sector (XLF) | 70.5% | 13.6% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| ARCI Return | - | - | - | - | - | 1% | 1% |
| Peers Return | 79% | -36% | -49% | 1% | -24% | 232% | 50% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 10% | 101% |
Monthly Win Rates [3] | |||||||
| ARCI Win Rate | - | - | - | - | - | 67% | |
| Peers Win Rate | 50% | 25% | 33% | 42% | 17% | 52% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 60% | |
Max Drawdowns [4] | |||||||
| ARCI Max Drawdown | - | - | - | - | - | - | |
| Peers Max Drawdown | -31% | -41% | -60% | -44% | -45% | -1% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: BEBE, ACAA, AEAQ, ALOV, ALUB.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/29/2026 (YTD)
How Low Can It Go
ARCI has limited trading history. Below is the Financials sector ETF (XLF) in its place.
| Event | XLF | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -15.5% | -18.8% |
| % Gain to Breakeven | 18.4% | 23.1% |
| Time to Breakeven | 80 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -10.7% | -9.5% |
| % Gain to Breakeven | 12.0% | 10.5% |
| Time to Breakeven | 26 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -16.1% | -6.7% |
| % Gain to Breakeven | 19.1% | 7.1% |
| Time to Breakeven | 270 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -22.3% | -24.5% |
| % Gain to Breakeven | 28.6% | 32.4% |
| Time to Breakeven | 467 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -42.8% | -33.7% |
| % Gain to Breakeven | 74.8% | 50.9% |
| Time to Breakeven | 289 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -19.7% | -19.2% |
| % Gain to Breakeven | 24.5% | 23.8% |
| Time to Breakeven | 123 days | 105 days |
In The Past
State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
ARCI has limited trading history. Below is the Financials sector ETF (XLF) in its place.
| Event | XLF | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -22.3% | -24.5% |
| % Gain to Breakeven | 28.6% | 32.4% |
| Time to Breakeven | 467 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -42.8% | -33.7% |
| % Gain to Breakeven | 74.8% | 50.9% |
| Time to Breakeven | 289 days | 140 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -21.4% | -12.2% |
| % Gain to Breakeven | 27.3% | 13.9% |
| Time to Breakeven | 272 days | 62 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -26.1% | -17.9% |
| % Gain to Breakeven | 35.3% | 21.8% |
| Time to Breakeven | 162 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -78.3% | -53.4% |
| % Gain to Breakeven | 359.8% | 114.4% |
| Time to Breakeven | 2329 days | 1085 days |
In The Past
State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Archimedes Tech SPAC Partners III (ARCI)
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
AI Analysis | Feedback
For its pharmaceutical business, imagine a smaller Eli Lilly focused on developing non-addictive pain medications.
For its appliance recycling segment, think of Best Buy's recycling services, but as a B2B offering for utility companies.
For its cellular technology segment, it's like a niche hardware provider similar to a tiny Qualcomm, making cellular modules for wireless devices.
AI Analysis | Feedback
- JAN101: A patented oral and sustained release pharmaceutical composition of sodium nitrite designed to treat pain by targeting poor blood flow in patients with diabetes or peripheral artery disease.
- Appliance Recycling and Replacement Services: Turnkey services provided for utilities and other sponsors of energy efficiency programs.
- Cellular Transceiver Modules and Wireless Services: Design, development, and sale of cellular transceiver modules and associated wireless services.
AI Analysis | Feedback
JanOne Inc. (trading as ARCI) primarily sells its products and services to other companies, not individuals directly. Based on the provided description, specific names of customer companies are not listed, but the company serves the following categories of business customers across its three segments:
- Utilities and Sponsors of Energy Efficiency Programs: For its Recycling segment, JanOne Inc. provides turnkey appliance recycling and replacement services to these entities.
- Healthcare Providers and Pharmaceutical Distributors: For its Biotechnology segment, once its lead product candidate, JAN101, is commercialized, it would typically be sold to hospitals, pharmacies, and pharmaceutical wholesalers and distributors.
- Manufacturers and Businesses Utilizing Cellular Communication Technology: For its Technology segment, the company designs, develops, and sells cellular transceiver modules and associated wireless services, primarily targeting manufacturers of devices that incorporate these modules and businesses that require these wireless services.
AI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
Archimedes Tech SPAC Partners III (ARCI) is a special purpose acquisition company (SPAC) that focuses on identifying and merging with businesses in the technology industry, particularly in artificial intelligence, cloud services, and automotive technology sectors. As a SPAC, its key risks are primarily associated with its ability to successfully execute its business objective. Here are the key risks to Archimedes Tech SPAC Partners III: *Failure to Complete a Business Combination
The most significant risk for Archimedes Tech SPAC Partners III is its potential inability to identify and complete an initial business combination within the timeframe specified in its organizational documents. If the SPAC fails to consummate a merger or acquisition within this period, it would be forced to liquidate, returning the trust account funds to its public stockholders. In such a scenario, public shareholders would only receive their initial investment back, without any return or potential upside from an operating business. *Difficulty Identifying a Suitable Acquisition Target
Archimedes Tech SPAC Partners III intends to focus its search for businesses in competitive and rapidly evolving sectors such as artificial intelligence, cloud services, and automotive technology. Identifying a suitable target company that aligns with its investment criteria, agrees to acceptable terms, and meets all regulatory requirements can be challenging. The competitive landscape for attractive acquisition targets among other SPACs and traditional buyers may make it difficult to secure a desirable merger candidate. *Redemption Risk and Potential Dilution
Even if Archimedes Tech SPAC Partners III announces a proposed business combination, public shareholders have the right to redeem their shares. High redemption rates by public shareholders can significantly reduce the amount of cash available to the combined company, potentially impacting its future operations, growth plans, or ability to raise additional capital on favorable terms. This could also lead to greater dilution for non-redeeming shareholders if additional equity financing is required.AI Analysis | Feedback
The rapid evolution and advancement of wireless communication technologies, such as the ongoing development and deployment of 5G, the emergence of 6G, and new specialized IoT communication protocols, pose a significant emerging threat to JanOne Inc.'s Technology segment. This segment designs, develops, and sells cellular transceiver modules and associated wireless services. The constant innovation from major semiconductor firms (e.g., Qualcomm, MediaTek) in integrating more functionality into System-on-Chips (SoCs) and driving down costs could lead to the accelerated obsolescence of JanOne's specific module designs. This dynamic could make it increasingly difficult for JanOne to compete on innovation, scale, or cost with larger players offering more integrated and advanced solutions, similar to how new mobile paradigms disrupted earlier hardware manufacturers.
AI Analysis | Feedback
For Archimedes Tech SPAC Partners III (ARCI), which operates as JanOne Inc., the addressable markets for its main products and services are as follows:
-
JAN101 (Non-opioid therapies for pain related to poor blood flow in diabetes or peripheral artery disease):
- The global non-opioid pain treatment market was estimated at approximately USD 48.38 billion in 2024 and is projected to reach around USD 96.25 billion by 2034.
- The global diabetic neuropathy treatment market was valued at approximately USD 5.8 billion in 2024, with a projected compound annual growth rate (CAGR) of 7.1% to reach about USD 8.74 billion by 2030.
-
Turnkey appliance recycling and replacement services:
- The global home appliance recycling market was anticipated to be approximately USD 18.8 billion in 2024 and is projected to expand to USD 38.3 billion by 2034, growing at a CAGR of approximately 7.4%. In 2025, this market is estimated to be valued at USD 21.26 billion.
-
Cellular transceiver modules and associated wireless services:
- The global cellular IoT module market is estimated to be valued at approximately USD 25.7 billion in 2025 and is projected to reach USD 210.4 billion by 2035, exhibiting a CAGR of 23.4%. The global IoT module market size was valued at USD 20.83 billion in 2024.
AI Analysis | Feedback
nullAI Analysis | Feedback
NullTrade Ideas
Select ideas related to ARCI.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 04302026 | EEFT | Euronet Worldwide | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 04242026 | HOMB | Home BancShares | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 1.5% | 1.5% | 0.0% |
| 03312026 | HBAN | Huntington Bancshares | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 7.1% | 7.1% | 0.0% |
| 03312026 | NP | Neptune Insurance | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 3.9% | 3.9% | 0.0% |
| 03272026 | JKHY | Jack Henry & Associates | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 0.3% | 0.3% | -4.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 9.99 |
| Mkt Cap | 0.3 |
| Rev LTM | - |
| Op Inc LTM | - |
| FCF LTM | - |
| FCF 3Y Avg | - |
| CFO LTM | - |
| CFO 3Y Avg | - |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | - |
| Rev Chg 3Y Avg | - |
| Rev Chg Q | - |
| QoQ Delta Rev Chg LTM | - |
| Op Inc Chg LTM | - |
| Op Inc Chg 3Y Avg | - |
| Op Mgn LTM | - |
| Op Mgn 3Y Avg | - |
| QoQ Delta Op Mgn LTM | - |
| CFO/Rev LTM | - |
| CFO/Rev 3Y Avg | - |
| FCF/Rev LTM | - |
| FCF/Rev 3Y Avg | - |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 0.3 |
| P/S | - |
| P/Op Inc | - |
| P/EBIT | - |
| P/E | - |
| P/CFO | - |
| Total Yield | - |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | - |
| D/E | 0.0 |
| Net D/E | -0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 0.4% |
| 3M Rtn | 1.0% |
| 6M Rtn | 1.0% |
| 12M Rtn | 1.0% |
| 3Y Rtn | 1.0% |
| 1M Excs Rtn | -5.8% |
| 3M Excs Rtn | -9.2% |
| 6M Excs Rtn | -11.0% |
| 12M Excs Rtn | -27.7% |
| 3Y Excs Rtn | -81.8% |
Earnings Returns History
Updated N/A/N/A/N/A| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Multi-Sector Holdings Resources |
| McKinsey & Company Insights |
| Harvard Business Review |
| ValueWalk |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.
Core Cache Last Updated: 5/31/2026